Ligand validation:2ZUV

NDG: 2-acetamido-2-deoxy-alpha-D-glucopyranose

NDG is a Ligand Of Interest in 2ZUV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2ZUV_NDG_A_2001	97%	50%	0.066	0.978	0.54	1.38	-	2	0	0	100%	1
2ZUV_NDG_B_2002	90%	55%	0.099	0.982	0.59	1.13	-	2	0	0	100%	1
3WFZ_NDG_D_801	84%	55%	0.1	0.962	0.51	1.2	-	1	0	0	100%	1
2ZUU_NDG_D_4004	84%	57%	0.118	0.98	0.51	1.14	-	1	0	0	100%	1
2ZUW_NDG_B_4002	80%	50%	0.098	0.947	0.63	1.27	-	2	0	0	100%	1
4GVF_NDG_A_401	97%	29%	0.06	0.978	1.66	1.18	4	2	0	0	100%	0.7
2UVO_NDG_B_1176	97%	71%	0.059	0.975	0.42	0.68	-	-	0	0	100%	1
5A3L_NDG_C_1237	96%	58%	0.066	0.974	0.44	1.15	-	2	0	0	100%	0.5
8R3D_NDG_E_101	96%	54%	0.057	0.963	0.78	0.98	1	1	0	0	100%	1
8R3C_NDG_G_101	93%	52%	0.061	0.955	0.64	1.22	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.